Industry News
High-tech glasses help surgeons see cancer cells
Feb 13, 2014
Researchers at Washington University School of Medicine in St. Louis, MO, have developed a way of visualizing cancer cells using high-tech glasses designed to make it easier for surgeons to distinguish between cancerous and healthy tissue. Read More
Prostate cancer advance could improve treatment options
Feb 13, 2014
Researchers at the University of East Anglia have made an important advance in understanding genetic changes associated with terminal prostate cancer.Findings published today in the British Journal of Cancer, and funded by the Association for International Cancer Research (AICR), show how a genetic mutation in untreated patients is linked to aggressive cancer later in life. Read More
Proton therapy for prostate cancer results in long-term patient survival and excellent quality of life
Feb 13, 2014
Five years after having proton therapy for early- and intermediate-risk prostate cancer, 99 percent of men are living cancer-free and with excellent quality of life, according to a University of Florida Proton Therapy Institute study. Three-quarters of those with high-risk prostate cancer are also disease-free. Read More
New breast cancer treatment Kadcyla given green light by regulators, UK
Feb 13, 2014
Kadcyla is now available for patients with advanced HER2-positive breast cancer. Kadcyla is the first medicine of its kind in breast cancer, consisting of the HER2-targeted antibody, trastuzumab (contained in the medicine Herceptin), linked with the chemotherapy agent, DM1. Read More
Schizophrenia enters the molecular diagnostics era
Feb 13, 2014
With a drop of blood and some laboratory analyses, doctors have been able to tell patients whether they suffer from diabetes or some sort of cancer. Measuring changes in the cells or molecules of human tissues or fluids, by detecting so-called biomarkers, has aided the diagnosis of various diseases for some time. Read More
Prostate cancer advance could improve treatment options
Feb 13, 2014
Researchers at the University of East Anglia have made an important advance in understanding genetic changes associated with terminal prostate cancer.Findings published today in the British Journal of Cancer, and funded by the Association for International Cancer Research (AICR), show how a genetic mutation in untreated patients is linked to aggressive cancer later in life. Read More
Proton therapy for prostate cancer results in long-term patient survival and excellent quality of life
Feb 13, 2014
Five years after having proton therapy for early- and intermediate-risk prostate cancer, 99 percent of men are living cancer-free and with excellent quality of life, according to a University of Florida Proton Therapy Institute study. Three-quarters of those with high-risk prostate cancer are also disease-free. Read More
New breast cancer treatment Kadcyla given green light by regulators, UK
Feb 13, 2014
Kadcyla is now available for patients with advanced HER2-positive breast cancer. Kadcyla is the first medicine of its kind in breast cancer, consisting of the HER2-targeted antibody, trastuzumab (contained in the medicine Herceptin), linked with the chemotherapy agent, DM1. Read More
Schizophrenia enters the molecular diagnostics era
Feb 13, 2014
With a drop of blood and some laboratory analyses, doctors have been able to tell patients whether they suffer from diabetes or some sort of cancer. Measuring changes in the cells or molecules of human tissues or fluids, by detecting so-called biomarkers, has aided the diagnosis of various diseases for some time. Read More
New target isolated for acute myeloid leukemia drug development
Feb 13, 2014
There are potentially effective treatments for acute myeloid leukemia (AML), but they only work in 20 to 40 percent of cases. Read More
Previous Page Next Page